Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Related financial report
ZVRA similar filings
- 17 Jun 22 Changes in Registrant's Certifying Accountant
- 31 May 22 Entry into a Material Definitive Agreement
- 16 May 22 KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline
- 12 May 22 KemPharm Reports First Quarter 2022 Financial Results and Corporate Updates
- 30 Mar 22 KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates
- 21 Mar 22 KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
- 16 Mar 22 KemPharm team provided development and regulatory services to Corium pursuant to a master development services agreement
Filing view
External links
Exhibit 99.2
![slide1.jpg](https://capedge.com/proxy/8-K/0001437749-22-012157/slide1.jpg)
![slide2.jpg](https://capedge.com/proxy/8-K/0001437749-22-012157/slide2.jpg)
![slide3.jpg](https://capedge.com/proxy/8-K/0001437749-22-012157/slide3.jpg)
![slide4.jpg](https://capedge.com/proxy/8-K/0001437749-22-012157/slide4.jpg)
![slide5.jpg](https://capedge.com/proxy/8-K/0001437749-22-012157/slide5.jpg)
![slide6.jpg](https://capedge.com/proxy/8-K/0001437749-22-012157/slide6.jpg)
![slide7.jpg](https://capedge.com/proxy/8-K/0001437749-22-012157/slide7.jpg)
![slide8.jpg](https://capedge.com/proxy/8-K/0001437749-22-012157/slide8.jpg)
![slide9.jpg](https://capedge.com/proxy/8-K/0001437749-22-012157/slide9.jpg)
![slide10.jpg](https://capedge.com/proxy/8-K/0001437749-22-012157/slide10.jpg)
![slide11.jpg](https://capedge.com/proxy/8-K/0001437749-22-012157/slide11.jpg)